WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Yuanliang Yan
PeerJ Author & Reviewer
2,620 Points

Contributions by role

Author 635
Reviewer 15
Editor 1,970

Contributions by subject area

Bioinformatics
Oncology
Pharmacology
Respiratory Medicine
Molecular Biology
Biochemistry
Epidemiology
Otorhinolaryngology
Gastroenterology and Hepatology
Medical Genetics
Cell Biology
Women's Health
Computational Biology
Genomics
Cardiology
Nephrology
Evidence Based Medicine
Neurology
Radiology and Medical Imaging
Internal Medicine
Surgery and Surgical Specialties
Hematology
Immunology
Public Health
Psychiatry and Psychology
Data Mining and Machine Learning
Mental Health
Anesthesiology and Pain Management
Clinical Trials
Obesity
Drugs and Devices
Pediatrics
Cognitive Disorders
Histology
Pathology

Yuanliang Yan

PeerJ Author & Reviewer

Summary

Prof. Yuanliang Yan is an Associate Professor at Xiangya Hospital, Central South University, Hunan, China. She is also a Visiting Researcher at the Mayo Clinic in Minnesota, USA.

Prof. Yan obtained her Medical Degree (2007-2011) at Xiangya School of Medicine, Central South University. Following her research training, she was awarded a Masters Degree (2011-2014) and Doctoral Degree (2016-2019) at Xiangya Hospital, Central South University.

Prof. Yan's specialization is Pharmaceutics and Pharmacology. She has received systematic training in anti-cancer treatment at Xiangya Hosital, Central South University, China and Mayo Clinic, USA. Prof. Yan's research mainly focuses on cancer therapy, with an ultimate goal of translating mechanistic insights gained for new therapeutic modalities. She has published approximately 100 research papers in prestigious journals, including Molecular Cancer (IF=27.401), Nucleic Acids Research (IF=16.971), Journal of Hematology and Oncology (IF=17.388), Journal of Thoracic Oncology (IF=13.357), and Acta Pharmaceutica Sinica B (IF=11.413). Presently, she also serves as the Associate Editor for BMC Pulmonary Medicine, Frontiers in Pharmacology, and Technology in Cancer Research & Treatment.

Bioinformatics Cardiology Cell Biology Gastroenterology & Hepatology Metabolic Sciences Molecular Biology Neuroscience Oncology Pathology Pharmacology Public Health

Work details

Associate Professor

Xiangya Hospital, Central South University
July 2014
Department of Pharmacy

Websites

  • PubMed Search

PeerJ Contributions

  • Articles 6
  • Edited 15
February 2, 2023
FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
Wei Zhu, Meiyuan Huang, Abhimanyu Thakur, Yuanliang Yan, Xiaoying Wu
https://doi.org/10.7717/peerj.14827 PubMed 36751636
September 15, 2021
Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration
Yuanliang Yan, Qiuju Liang, Zhijie Xu, Qiaoli Yi
https://doi.org/10.7717/peerj.12171 PubMed 34616622
September 1, 2021
The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma
Bi Peng, Yuanliang Yan, Zhijie Xu
https://doi.org/10.7717/peerj.12123 PubMed 34557360
December 10, 2019
Retrospective clinical study of renin-angiotensin system blockers in lung cancer patients with hypertension
Jie Wei, Zhiyang Zhou, Zhijie Xu, Shuangshuang Zeng, Xi Chen, Xiang Wang, Wanli Liu, Min Liu, Zhicheng Gong, Yuanliang Yan
https://doi.org/10.7717/peerj.8188 PubMed 31844581
September 3, 2019
Identification of Aloperine as an anti-apoptotic Bcl2 protein inhibitor in glioma cells
Zhijie Xu, Xiang Wang, Xi Chen, Shuangshuang Zeng, Long Qian, Jie Wei, Zhicheng Gong, Yuanliang Yan
https://doi.org/10.7717/peerj.7652 PubMed 31534865
June 17, 2019
A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma
Xiang Wang, Zhijie Xu, Xi Chen, Xinxin Ren, Jie Wei, Shuyi Zhou, Xue Yang, Shuangshuang Zeng, Long Qian, Geting Wu, Zhicheng Gong, Yuanliang Yan
https://doi.org/10.7717/peerj.7125 PubMed 31245181

Academic Editor on

May 28, 2024
Erector spinae plane block versus paravertebral block on postoperative quality of recovery in obese patients undergoing laparoscopic sleeve gastrectomy: a randomized controlled trial
Guanyu Yang, Pengfei Wang, Yue Yin, Huan Qu, Xin Zhao, Xiaogao Jin, Qinjun Chu
https://doi.org/10.7717/peerj.17431 PubMed 38827293
April 26, 2024
A CT-based integrated model for preoperative prediction of occult lymph node metastasis in early tongue cancer
Wei Han, Yingshu Wang, Tao Li, Yuke Dong, Yanwei Dang, Liang He, Lianfang Xu, Yuhao Zhou, Yujie Li, Xudong Wang
https://doi.org/10.7717/peerj.17254 PubMed 38685941
April 19, 2024
Meta-analysis of the correlation between pulmonary hypertension and echocardiographic parameters in patients with chronic kidney disease
Jiahui Jin, Wen Hao, Deqiong Xie
https://doi.org/10.7717/peerj.17245 PubMed 38650651
January 29, 2024
The impact of the route of administration on the efficacy and safety of the drug therapy for patent ductus arteriosus in premature infants: a systematic review and meta-analysis
Hanwen Luo, Jianghua He, Xiaoming Xu, Hongju Chen, Jing Shi
https://doi.org/10.7717/peerj.16591 PubMed 38304184
January 16, 2024
XYA-2: a marine-derived compound targeting apoptosis and multiple signaling pathways in pancreatic cancer
Xiaoqing Guan, Yun Li, Xiaodan Guan, Linfei Fan, Jieer Ying
https://doi.org/10.7717/peerj.16805 PubMed 38250721
December 21, 2023
A systematic review and meta-analysis of magnetic resonance and computed tomography enterography in the diagnosis of small intestinal tumors
Ruitao Li, Shengqiang Ye, Chenglong Zhou, Feng Liu, Xiaonan Li
https://doi.org/10.7717/peerj.16687 PubMed 38144202
October 31, 2023
The efficacy of digital cognitive behavioral therapy for insomnia and depression: a systematic review and meta-analysis of randomized controlled trials
Wenyao Lin, Na Li, Lili Yang, Yuqing Zhang
https://doi.org/10.7717/peerj.16137 PubMed 37927792
September 25, 2023
Berberine protects hepatocyte from hypoxia/reoxygenation-induced injury through inhibiting circDNTTIP2
Yi Zhu, Junhui Li, Pengpeng Zhang, Bo Peng, Cai Li, Yingzi Ming, Hong Liu
https://doi.org/10.7717/peerj.16080 PubMed 37780378
August 21, 2023
Early haemodynamic predictors of poor functional outcomes in patients with acute ischaemic stroke receiving endovascular therapy: a single-centre retrospective study in China
Yanyan Hu, Shizhong Zhang, Jiajun Zhang, Xin Wang, Feng Zhang, Hong Cui, Hui Yuan, Wei Zheng
https://doi.org/10.7717/peerj.15872 PubMed 37637153
June 12, 2023
Remimazolam versus propofol for procedural sedation: a meta-analysis of randomized controlled trials
Yu Chang, Yun-Ting Huang, Kuan-Yu Chi, Yen-Ta Huang
https://doi.org/10.7717/peerj.15495 PubMed 37334113
May 31, 2023
The significance of PD-1/PD-L1 imbalance in ulcerative colitis
Wei Shi, Yu Zhang, Chonghua Hao, Xiaofeng Guo, Qin Yang, Junfang Du, Yabin Hou, Gaigai Cao, Jingru Li, Haijiao Wang, Wei Fang
https://doi.org/10.7717/peerj.15481 PubMed 37273534
May 11, 2023
Higher serum β2-microglobulin is a predictive biomarker for cognitive impairment in spinal cord injury
Zhonghao Cui, Shuai Wang, Yanke Hao, Yuanzhen Chen
https://doi.org/10.7717/peerj.15372 PubMed 37193029
March 7, 2023
RNA-seq reveals Nup62 as a potential regulator for cell division after traumatic brain injury in mice hippocampus
Jianwei Zhao, Weihua Wang, Ke Yan, Haifeng Zhao, Zhen Zhang, Yu Wang, Wenyu Zhu, Shiwen Chen
https://doi.org/10.7717/peerj.14913 PubMed 36908815
February 7, 2023
The imbalance of liver resident macrophages polarization promotes chronic autoimmune hepatitis development in mice
Gang Chi, Jinhong Pei, Xueqing Li
https://doi.org/10.7717/peerj.14871 PubMed 36778150
December 21, 2022
OPA1 supports mitochondrial dynamics and immune evasion to CD8+ T cell in lung adenocarcinoma
Ying Wang, Yadong Li, Xuanwei Jiang, Yayun Gu, Hui Zheng, Xiaoxuan Wang, Haotian Zhang, Jixiang Wu, Yang Cheng
https://doi.org/10.7717/peerj.14543 PubMed 36573240